1. New biomarkers for neuroblastoma, a type of cancer in children

    New biomarkers for neuroblastoma, a type of cancer in children

    Two new biomarkers for a type of cancer in children called neuroblastoma have been identified in a study published in the journal Cancer Cell.

    The findings are expected to have immediate significance for disease prognosis, and eventually also for...

    Read Full Article
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Drug Development, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Quotes

    1. There is a need for new methods of treatment for high-risk patients, and that's where our research can lead to truly great benefits.
    2. Epigenetic drugs activate the RNA molecules in question and thereby forestall the tumour, and in this way it will be possible to go in and treat high-risk patients.
  3. Topics Mentioned